POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study

Authors :: X. Wang
L. Lixuan
L. Zhihong
C. Yinghua
L. Zhengzhao
W. Hu
G. Erzhi
C. Duqun
Source :: Kidney International Reports, Vol 6, Iss 4, Pp S140-(2021)
Publication Year :: 2021
Publisher :: Elsevier, 2021.

Subjects :: Oncology
medicine.medical_specialty
Ultra low dose
business.industry
Lupus nephritis
medicine.disease
Diseases of the genitourinary system. Urology
Regimen
Nephrology
Internal medicine
medicine
Observational study
Rituximab
RC870-923
business
medicine.drug

Tools